Episodes
-
Tempus AI Buys Personalis for $1.5B in MRD Cancer Push
Tue, Jul 21, 2026
-
GSK Kills Camlipixant: The P2X3 Cough Bet Just Went to Zero
Sun, Jul 19, 2026
-
GSK Kills Camlipixant: The $2B Bellus Bet Unravels
Sat, Jul 18, 2026
-
Merck's Sac-TMT Beats Chemo in Lung Cancer — Keytruda's Cliff Answer
Thu, Jul 16, 2026
-
Celcuity Revtorpyk Approved: The Label Line That Makes It a Takeout Target
Wed, Jul 15, 2026
-
GSK to File Jemperli in Rectal Cancer After Phase 2 Win
Tue, Jul 14, 2026
-
AstraZeneca's Wainua Stumbles: The Clinic Pushed Back on Pharma's Deal Boom
Mon, Jul 13, 2026
-
GSK Ends Alector Neuroscience Bet: What the $2.2B Unwind Signals
Sat, Jul 11, 2026
-
Wainua Fails Pivotal ATTR-CM Trial; Ionis Sinks 20%
Fri, Jul 10, 2026
-
FDA Halts Drug Rejection Letters — What It Means for Competitive Intel
Thu, Jul 9, 2026
-
Vera's TRUTAKNA Wins FDA Nod: The eGFR Readout That Decides the IgAN Race
Wed, Jul 8, 2026
-
Vertex Buys Crinetics for $10B in Endocrinology Push
Tue, Jul 7, 2026
-
Enbrel Price Cap Blocked: One Ruling That Could Reshape States Drug Pricing
Sat, Jul 4, 2026
-
Tregzi Approved — Orca Bio Opens a New Lane in Cell Therapy
Thu, Jul 2, 2026
-
NEJM Retracts Tavneos Pivotal Trial; Ionis Tryngolza PDUFA Today
Wed, Jul 1, 2026
-
FDA Approves Viridian for Thyroid Eye Disease; Merck KGaA's $11.3B Bio-Techne Deal
Sat, Jun 27, 2026
-
Ionis Tryngolza FDA Label Expansion Hits Commercial Inflection
Fri, Jun 26, 2026
-
FDA Approves Gilead's Trodelvy for Front-Line TNBC; Lilly's $1.9B Abbisko Deal
Thu, Jun 25, 2026
-
Pfizer Seagen ADC Fails in Lung Cancer Phase 3; CMS Settles Opzelura Classification
Wed, Jun 24, 2026
-
AbbVie's $10.9B Apogee Buy Targets Dupixent; 1st Solid Tumor CAR-T Approved in China
Tue, Jun 23, 2026
-
US Probes Germany Drug Pricing; Moderna Flu Vaccine Wins Unanimous FDA Panel
Sat, Jun 20, 2026
-
Moderna mFlusiva Wins Unanimous VRBPAC Vote; NovoCure TRIDENT Fails in GBM
Fri, Jun 19, 2026
-
UniQure AMT-130 Surges 70% on FDA Reversal; Jazz-AbCellera $4.1B TCE Deal
Thu, Jun 18, 2026
-
BridgeBio BBP-418 Sweeps LGMD Phase 3; FDA Scrutinizes Moderna Flu Vaccine
Wed, Jun 17, 2026
-
CMS Targets SubQ Keytruda and Opdivo Loophole; Takeda Beats Sotyktu Head-to-Head
Tue, Jun 16, 2026
-
EHA 2026 Special — Full Meeting Recap
Mon, Jun 15, 2026
-
FDA Approves Merck Welireg-Keytruda for Kidney Cancer; Jazz Zepzelca Phase 3 Fails
Sat, Jun 13, 2026
-
Takeda Zasocitinib Beats Sotyktu in Head-to-Head Phase 3; Summit Pulls $500M Offering
Fri, Jun 12, 2026
-
Parabilis Sets Record $670M Biotech IPO; Sanofi Halts Riliprubart Phase 3
Thu, Jun 11, 2026
-
The Pharma Closeout Special Report
Mon, Jun 8, 2026
-
SCOTUS Backs Hikma Skinny-Label Win on Vascepa; ADC Therapeutics Crashes 50% on Death
Fri, Jun 5, 2026
-
ASCO 2026 Special, Part 2 — ThClosing Days: Iza-bren Doubles Down in TNBC & Esophageal
Wed, Jun 3, 2026
-
ASCO 2026 Special — Comprehensive Opening Weekend: Daraxonrasib Doubles Pancreatic OS
Mon, Jun 1, 2026
-
Pfizer's $10.5B Innovent Deal Extends China Licensing Wave; BMS Mezigdomide Phase 3
Sat, May 30, 2026
-
GSK/Ionis Bepirovirsen Achieves 19% Functional Cure in Hepatitis B
Fri, May 29, 2026
-
Pfizer's Next-Gen Pneumonia Vaccine Beats Prevnar 20; BMS Deploys Anthropic AI
Thu, May 21, 2026
-
Regeneron LAG-3 Phase 3 Failure Crashes Stock 11%; Supreme Court Cements IRA
Tue, May 19, 2026
-
FDA's CDER Chief Høeg Expected to Exit; Tecentriq Wins Bladder Cancer Approval
Sun, May 17, 2026
-
AstraZeneca Imfinzi Phase 3 Win in Bladder Cancer; Gene Therapy Safety Overhang
Fri, May 15, 2026
-
BeOne's Beqalzi Wins FDA Approval, Breaking BCL-2 Monopoly; Takeda Cuts 4,500 Jobs
Thu, May 14, 2026
-
FDA Commissioner Makary Resigns; BMS-Hengrui $15.2B 13-Asset Alliance
Wed, May 13, 2026
-
CSL Flags $5B Vifor Impairment as Shares Hit Nine-Year Low
Tue, May 12, 2026
-
Vyvgart Wins Broadest gMG Label; Merck Closes $6.7B Terns Deal
Mon, May 11, 2026
-
Trump Plans to Fire FDA Commissioner Makary; Leqembi SC Delayed to August
Sat, May 9, 2026
-
Angelini's $4.1B Catalyst Buyout; Atara Surges 40% on FDA Path Forward; Roche Acquires PathAI
Fri, May 8, 2026